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Background. Much research is done on the stigma of mental illness, but little research has been done to characterize these
phenomena from the perspective of people with mood disorders. Objective. To characterize the extent to which individuals
with bipolar disorder and depression are stigmatized, determine factors related to higher levels of stigmatization, and assess the
reliability of the Inventory of Stigmatizing Experiences in a population of people with a mood disorder. Methods. Two hundred
andfourteenindividualswithdepressionandbipolardisorderwererecruitedfromatertiarycarepsychiatrichospitalandsurveyed
using the Inventory of Stigmatizing Experiences. Results. Participants reported high levels of stigma experiences and this did
not diﬀer by diagnosis (P = 0.578). However, people with bipolar disorder reported greater psychosocial impact of stigma on
themselves and their family members compared to people with depression (P = 0.019). The two subscales produced internally
consistent results with both populations. Conclusion. Stigma negatively aﬀects those with both depression and bipolar disorder but
appears to have a greater psychosocial impact on those with bipolar disorder.
1.Introduction
The experience of stigma associated with mental illness is
devastating and can be detrimental to recovery [1–4]. Link
and Phelan [5] deﬁnes stigma in terms of ﬁve interrelated
components: labeling, stereotyping, separation, status loss,
and discrimination. They further note that each of these
ﬁve elements must occur within a power diﬀerential, where
the stigmatized individual possesses a lesser amount of
power. Stigma is often the response to individuals who are
expressing an undesirable or frightening characteristic and
can be viewed as a continuum from intolerance or agitation
to prejudice and discrimination [6, 7]. On the more negative
end of the continuum, prejudice and discrimination are
rootedincommonlyheldstereotypesthatareassociatedwith
mental illnesses. These stereotypes are concentrated within
an image that individuals with a mental illness are unable
to make competent decisions, are dangerous to themselves
and/or the public, and require coercive intervention as
they will not seek treatment autonomously [8]. In fact,
the diagnosis of a mental illness is coupled with negative
stereotypes regardless of the presence of abnormal behavior
[9]. Although work has been done to reduce stigma and
educate the public about mental illnesses, signiﬁcant barriers
still exist to diﬀerentiate people with a mental illness from
mainstream society [10].
Social stigmatization of those with mental illnesses has
long been studied; however, the majority of analyses have
focusedontheknowledgeandattitudesofthegeneralpublic.
A number of inaccurate ideas about symptoms, etiology
and treatments have been identiﬁed [11–15]. Social distance
is used to measure peoples’ willingness to interact with
someone who has a mental illness. These studies have shown
that many people want to distance themselves from someone
who has a mental illness as much as they would with
someone with a drug dependency or someone who has been
convicted of a crime [12, 16].
Despite the interest in stigma associated with mental
illnesses,theperspectivesofpeoplewithamentalillnesshave
only rarely been studied [17]. Compared to the large body2 Depression Research and Treatment
of research assessing public stigma, there has comparatively
little work examining the stigma experienced by those with a
mental illness, particularly those with a mood disorder [17,
18]. The majority of research has instead focused on stigma
within populations of individuals with schizophrenia and
other psychotic disorders [17]. However, examining stigma
experienced by people with mood disorders is essential as
The World Health Organization identiﬁes depression as a
major contributor to the global burden of disease due to
“its relatively high lifetime prevalence and the signiﬁcant
disability that it causes” [19]. A qualitative study of stigma
by Dinos et al. [20] suggests that individuals with mood
and anxiety disorders may experience stigma diﬀerently
when compared to individuals with psychotic disorders
highlighting the importance of studying the eﬀects of stigma
on individuals with a variety of illnesses.
From the smaller body of research examining stigma
from the perspective of someone with a mental illness
[18], it has been reported that stigma may greatly aﬀect an
individual’s decision to seek treatment resulting in delaying
or avoiding treatment all together [21, 22]. In those who
do seek treatment, stigma may be partially responsible for
nonadherencetotreatmentregimens[1–3].Perceivedstigma
has also been shown to be related to reduced social func-
tioning in people with bipolar disorder [23] and impaired
functioning in the workplace for people with depression and
anxiety [7, 24]. Stigmatization can lead to negative feelings
about ones’ self-including: shame, self-derogation, feelings
of incompetence, and overall low self-esteem [25]. We know
of no work that has been done to quantify the degree to
which outpatients with mood disorders feel stigmatized and
are aware of no studies that have compared the diﬀerence in
stigma experienced by those with bipolar disorder compared
to major depressive disorder.
Our primary objective was to determine the extent to
which people experiencing a mood disorder report being
stigmatized.Oursecondaryobjectivewastocomparestigma-
tizing experiences of people with a major depressive disorder
tothosewithabipolardisorder.Wehypothesizedthathaving
a bipolar disorder would be associated with more stigma
than having unipolar depression. We also hypothesized that
earlier onset, unemployment, and previous hospitalizations
would be associated with greater stigma. A third objective
was to further assess the psychometric qualities (speciﬁcally,
the internal reliability) of the Inventory of Stigmatizing
Experiences in a sample of people with mood disorders. The
Inventory of Stigmatizing Experiences was developed as a
way to measure the impact of stigma and discrimination
from the perspective of someone with a mental illness [26].
In previous testing the Inventory scales were found to be
highly reliable in a heterogeneous sample with a variety of
mental illnesses.
2. Methods
This study was approved by the Queen’s University Health
Science and Aﬃliated Teaching Hospitals Research Ethics
Board. Patients attending a mood disorders outpatient
450 registered patients 
Wave 1 pilot study 
Waves 2 and 3 
48 patients
166 patients 
Total 214 patients 
Figure 1: Recruitment of the patient sample.
clinic were asked to complete the Inventory of Stigmatiz-
ing Experiences as an anonymous questionnaire. As there
were no epidemiological studies examining patient reported
experiences of stigma among patients with a mood disorder,
there were no prevalence data to gauge sample size estimates.
Between August 2003 and September 2007, we recruited
a convenience sample from the Mood Disorders Research
and Treatment Service in Kingston, ON, Canada, in three
separate study waves, according to the availability of research
funding and support. Two hundred and fourteen clients,
out of a total of 450 in the clinic, participated in this
research. Forty-eight came from a previous study using this
questionnaire [26] (see Figure 1). During the data collection
periods, all individuals attending the clinic were invited
to participate. Though staﬀ did not formally keep track
of refusals, they reported that virtually everyone that was
asked did agree to participate. Thus, we estimate that the
response rate was at least 80% but probably closer to
90%. There were no restrictions on age, gender, or eth-
nicity. All participants were registered patients and had
received a clinical diagnosis of a mood disorder. Participants
were recruited from the intake service and both inpatient
and outpatient mood disorders units. All individuals were
able to and gave written informed consent before partici-
pating. Because individuals who attended the clinic more
frequently would have had a greater probability of being
recruited, the sample is likely skewed toward clients with
more serious disorders and, perhaps, more experiences with
stigma.
2.1. Questionnaire. We used the Inventory of Stigmatizing
Experiences [26] to assess stigma experiences. Stigma was
deﬁnedas“negativefeelingspeoplehavetowardspeoplewith
a mental illness.” The questionnaire consists of a Stigma
Experiences Scale (measuring frequency and prevalence)
and a Stigma Impact Scale (measuring the intensity of
psychosocialimpact).Thisquestionnairehasbeenpreviously
tested for reliability in a heterogeneous sample of psychiatric
outpatients. Reliability coeﬃcients were high for both scales:
0.83 for the Stigma Experiences Scale and 0.91 for the
Stigma Impact Scale. With respect to scoring, thirteen ofDepression Research and Treatment 3
the ﬁfteen questions in the Stigma Experiences Scale were
answeredas“yes,”“unsure”and“no”theothertwoquestions
were answered as “never”, “rarely”, “Sometimes”, “Often,”
or “Always”. All items were recoded to reﬂect the presence
or absence of stigma (either “yes”, “often” or “always”),
with reverse scoring for some items. The Stigma Impact
Scale consisted of seven questions, four of which rate the
degree to which stigma negatively impacted their individual
quality of life, social contacts, family relations, and self-
esteem. The remaining three items rated the degree to
which stigma negatively impacted their family’s quality of
life, social contacts, and family relations. Each question was
rated on a scale from 0 (lowest possible amount) to 10
(highest possible amount). All responses, including clinical
characteristics and health care usage, were self-reported. The
questionnaire was administered either as a semistructured
interview with a trained member of the research team or
as a self-administered survey. The majority of participants
completed the questionnaire in interview format. Interviews
took place at the clinic or over the phone. Those who
choose to ﬁll in the questionnaire themselves were able to
complete it in a quiet room or at their homes and then
return it.
2.2. Statistical Methods. Socioclinical characteristics of the
study groups were described using one and two-way fre-
quency distributions with proportions. Internal consistency
of the scales was assessed using the Kuder-Richardson (KR
20) reliability coeﬃcient for the experiences scale, which was
composed of binary items, and Chronbach’s alpha for the
impact scale, which was composed of interval data. Item-
rest correlations of.40 or less were considered to indicate
potentially problematic scale items. These were further
assessed by removing them from the scale reliability calcu-
lation. If the coeﬃcient of reliability was not substantially
improved, then the items were retained. Diﬀerences in the
stigma experiences of diagnostic groups were assessed using
least squares regression with casewise deletion for missing
data. Diagnostic group (Major Depression versus Bipolar
Disorder) was regressed on each stigma subscale separately
withsocio-clinicalvariablesaddediterativelyusingaforward
entry procedure. Confounding was not evident in any of
the models constructed. The ﬁnal model includes only those
variables with statistically signiﬁcant direct eﬀects. Only
participants who answered all scale questions were included
in the analyses.
3. Results
3.1. Sociodemographic and Clinical Characteristics. Table 1
summarizes the socio-clinical characteristics of study sub-
jects by diagnostic group. The majority were female. Ages
ranged from 20 to 70, but the majority were between 40 and
59years.Seventypercenthadcollegeoruniversityeducation,
but less than one-third were employed. Approximately half
were married and living with a spouse or partner. Less than
half considered that their mental health was better now
than a year ago, and almost a third thought it was worse.
For most, symptoms were ﬁrst noticed during adolescence
or young adulthood. Over a third received treatment within
the ﬁrst year after their symptoms emerged, but a quarter
did not receive treatment for more than ten years after
their ﬁrst symptoms. Three quarters had been ill for more
than ten years and the majority indicated they had come to
accept their diagnosis. Hospital use information was poorly
reported with large numbers of missing items—perhaps
because this was an outpatient sample with little hospital
experience. These questions may have been skipped. We have
calculated the valid percents, excluding the missing values.
Over a third had been hospitalized in the year prior to the
survey, seldom as an involuntary patient. Most (two-thirds)
were receiving regular outpatient community mental health
treatment. A greater percentage of respondents with Bipolar
Disorder were male, 50–59 years, not employed, living
alone, previously hospitalized for a mental illness or suicide
attempt,andconsideredtheirmentalhealthhadimprovedin
the previous year. A greater percentage of respondents with
depression were university trained, married (or common-
law), living with a spouse or partner, and ill less than ten
years.
3.2. Experience of Stigma. Table 2 summarizes the percent
of items endorsed for each of the 10 items comprising
the Stigma Experiences Scale for each diagnostic group
with reliability coeﬃcients and mean scale scores. All of
the scale items were endorsed by a third or more of the
respondents and the three items most frequently endorsed
(by two-thirds of respondents or more) were the same
for each diagnostic group: expectations that the average
person would be afraid of someone with a serious mental
illness, experiences with stigma having caused them to
think less about themselves, and avoiding situations that
may be stigmatizing. The item-rest correlations showed that
one item was potentially “problematic” but only among
people with self-reported depression. In this group, the
item measuring the extent to which the average person is
thought to be afraid of someone with a mental illness had
an item-rest correlation of 0.17. However, Kuder-Richardson
coeﬃcients indicated that this sub-scale produced internally
consistent data in both groups—well above the minimum
conventional cut point of 0.70. The internal consistency of
the scale among those with depression was not improved
when this item was removed (KR 20 = 0.788) so it was
retained for theoretical as well as practical reasons. The
mean scale scores were not signiﬁcantly diﬀerent, suggesting
similar types of stigma experiences occurred within each
group.
3.3. Impact of Stigma on Personal and Family Life. Table 3
summarizes the mean item scores and reliability coeﬃcients
for the 7-item Stigma Impact Scale. Mean item scores were
higherforthosewithBipolarDisorder—adiﬀerencethatwas
statistically signiﬁcant (t117df = 2.38, P = 0.019). Item-rest
correlations showed that all items performed well with high
alphas for both groups.4 Depression Research and Treatment
Table 1: Social characteristics of participants (N = 190)
∗.
Characteristic Bipolar disorder % (N) Depression % (N)T o t a l % ( N)
Gender
Male 41.7% (35) 33.3% (35) 37.0% (70)
Female 58.3% (49) 66.7% (70) 63.0% (119)
Age group
20–29 8.4% (7) 10.7% (11) 9.7% (18)
30–39 15.7% (13) 15.5% (16) 15.6% (29)
40–49 33.7% (28) 35.0% (36) 34.4% (64)
50–59 37.3% (31) 30.1% (31) 33.3% (62)
60–70 4.8% (4) 8.7% (9) 7.0% (13)
Highest education
Public school or less 2.4% (2) 2.9% (3) 2.6% (5)
High school 29.8% (25) 24.8% (26) 27.0% (51)
College or technical training 39.3% (33) 37.1% (39) 38.1% (72)
University 28.6% (24) 35.2% (37) 32.3% (61)
Employment status
Employed 27.4% (23) 36.2% (38) 32.3% (61)
Not employed 72.6% (61) 63.8% (67) 67.7% (128)
Marital status
Single 56.0% (47) 47.6% (50) 51.3% (97)
Married/common law 44.0% (37) 52.4% (55) 48.7% (92)
Living situation
Alone 33.3% (28) 25.7% (27) 29.1% (55)
Spouse/partner 44.0% (37) 50.5% (53) 47.6% (90)
Parents 6.0% (5) 9.5% (10) 7.9% (15)
Other 16.7% (14) 14.3% (15) 15.3% (29)
Mental health now compared to a year ago
Better 52.4% (44) 34.3% (36) 42.3% (80)
About the same 23.8% (20) 30.5% (32) 27.5% (52)
Worse 23.8% (20) 35.2% (37) 30.2% (57)
Age that symptoms were ﬁrst noticed
10 or under 8.2% (7) 6.0% (6) 7.0% (13)
11–19 41.2% (35) 38.0% (38) 39.5% (73)
20–29 20.0% (17) 21.0% (21) 20.5% (38)
30–39 21.2% (18) 22.0% (22) 21.6% (40)
40+ 9.4% (8) 13.0% (13) 11.4% (21)
Number of years ill (as of survey completion)
10 or less 22.9% (19) 30.6% (30) 27.1% (49)
11–19 22.9% (19) 21.4% (21) 22.1% (40)
20–29 18.1% (15) 22.4% (22) 20.4% (37)
30–39 22.9% (19) 19.4% (19) 21.0% (38)
40–51 13.3% (11) 6.1% (6) 9.4% (17)
Age at ﬁrst treatment
2–19 22.5% (18) 16.8% (16) 19.4% (34)
20–29 25.0% (20) 30.5% (29) 28.0% (49)
30–39 30.0% (24) 28.4% (27) 29.1% (51)
40+ 22.5% (18) 24.2% (23) 23.4% (41)
Number of years between symptoms and ﬁrst treatment
Under 1 year 38.8% (31) 39.6% (36) 39.2% (67)
1-2 years 11.3% (9) 9.9% (9) 10.5% (18)
3–5 years 16.3% (13) 14.3% (13) 15.2% (26)
6–10 years 10.0% (8) 8.8% (8) 9.4% (16)
10+ years 23.8% (19) 27.5% (25) 25.7% (44)Depression Research and Treatment 5
Table 1: Continued.
Characteristic Bipolar disorder % (N) Depression % (N)T o t a l % ( N)
Have come to accept diagnosis
No 17.6% (15) 14.6% (15) 16.0% (30)
Yes 82.4% (70) 85.4% (88) 84.0% (158)
Years between treatment initiation and diagnosis acceptance
Not accepted 19.2% (15) 18.1% (15) 18.6% (30)
Less than 1 year 23.1% (18) 26.5% (22) 24.8% (40)
1–5 25.6% (20) 24.1% (20) 24.8% (40)
6–10 11.5% (9) 15.7% (13) 13.7% (22)
11–15 7.7% (6) 7.2% (6) 7.5% (12)
16–20 5.1% (4) 4.8% (4) 5.0% (8)
21–25 7.7% (6) 3.6% (3) 5.6% (9)
Ever hospitalized for a mental illness or suicide attempt
Yes 65.9% (56) 53.8% (56) 59.3% (112)
No 34.1% (29) 46.2% (48) 40.7% (77)
Unknown/missing (0) (1) (1)
Ever hospitalized in a provincial psychiatric institution
Yes 55.4% (31) 52.7% (29) 54.1% (60)
No 44.6% (25) 47.3% (26) 45.9% (51)
Unknown/missing (29) (50) (79)
Ever hospitalized in a general hospital psychiatric unit
Yes 78.6% (44) 67.3% (37) 73.0% (81)
No 21.4% (12) 32.7% (18) 27.0% (30)
Unknown (29) (50) (79)
Ever committed under provincial mental health legislation
Yes 38.2% (21) 11.1% (6) 24.8% (27)
No 61.8% (34) 88.9% (48) 75.2% (82)
Unknown/missing (30) (51) (81)
Ever remanded to a forensic unit under federal legislation
Yes 4.9% (2) 0.0% (0) 2.7% (2)
No 95.1% (39) 100.0% (33) 97.3% (72)
Unknown/missing (44) (72) (116)
Hospitalized as a voluntary patient in the last year
Yes 30.9% (17) 40.0% (22) 35.5% (39)
No 69.1% (38) 60.0% (33) 64.5% (71)
Unknown/missing (30) (50) (80)
Hospitalized as an involuntary patient in the last year
Yes 3.6% (2) 3.6% (2) 3.6% (4)
No 69.1% (38) 60.0% (33) 64.5% (71)
Unknown/missing (30) (50) (80)
Use of outpatient community mental health program in the last year
Yes 64.7% (55) 68.3% (71) 66.7% (126)
No 35.3% (30) 31.7% (33) 33.3% (63)
Unknown/Missing (0) (1) (1)
Frequency of outpatient treatment (N = 124)
Weekly 46.3% (25) 41.4% (29) 43.5% (54)
2-3 times per month 9.3% (5) 24.3% (17) 17.7% (22)
Monthly 22.2% (12) 21.4% (15) 21.8% (27)
Every 2-3 months 14.8% (8) 10.0% (7) 12.1% (15)
1-2 per year 7.4% (4) 1.9% (2) 4.8% (6)
∗Missing data for some items will mean that frequencies may not total.6 Depression Research and Treatment
Table 2: Reliability coeﬃcients for the 10-item Stigma Experience Scale.
Scale item
B i p o l a rD i s o r d e r( N = 79
∗) Depression (N = 90
∗)
% Endorsed Item-rest correlation % Endorsed Item-rest correlation
Do you think people will think
less of you if they know you have
a mental illness?
62.0% .32 61.1% .35
Do you think that the average
person is afraid of someone with
a serious mental illness?
69.6% .46 73.3% .17
Have you ever been teased,
bullied, or harassed because you
have a mental illness?
43.0% .44 36.7% .54
Have you felt that you have been
treated unfairly or that your
rights have been denied because
you have a mental illness?
53.2% .32 50.0% .49
Have your experiences with
stigma aﬀected your recovery?
51.9% .46 56.7% .60
Have your experiences with
stigma caused you to think less
about yourself or your abilities?
65.8% .45 71.1% .49
Have your experiences with
stigma aﬀected your ability to
make or keep friends?
49.4% .58 55.6% .45
Have your experiences with
stigma aﬀected your ability to
interact with your family?
55.7% .45 55.6% .42
Have your experiences with
stigma aﬀected your satisfaction
with or quality of life?
60.8% .48 70.0% .45
Do you try to avoid situations
that may be stigmatizing to you?




Mean Scale Score (SD)∗∗ 5.8(2.8) 6.0 (2.8)
CI 5.1–6.4 5.4–6.6
∗Note reduced sample size. Only respondents who answered all scale questions are included in the above table. ∗∗t (167 df) = .558, P = .578.
Table 4 shows the ﬁnal results of regression modeling
using stigma impact as the dependent variable, and stig-
ma experiences and diagnostic group as the independent
variables. Separate models regressing diagnostic group on
stigma experiences failed to reach statistical signiﬁcance.
The adjusted R2 values for the ﬁnal model in Table 4 show
that the stigma experiences scale was the strongest predictor
of stigma impact, accounting for 33.2% of the variance
explained. Diagnostic group explained an additional 5.2%
of the variance. No other demographic, social, or clinical
variables signiﬁcantly predicted stigma impact. Regression
coeﬃcients show that for every point increase on the Stigma
Experience Scale (i.e., for every additional stigma experience
reported), one would predict a 3.9 point increase in the
Stigma Impact Score. In addition, the model predicts that
those with a diagnosis of bipolar disorder would have an
average scale score 8.96 points higher overall compared to
those with depression. Regression diagnostics revealed that
assumptions for normality, linearity, homoscedasticity, and
collinearity were met.
4. Discussion
This study reports four main ﬁndings. First, the two scales
used to measure personal experiences with stigma and its
psychosocial impacts produce internally consistent results
when applied to groups with self-reported depression and
bipolar disorder. Reliability coeﬃcients were in the good to
excellent range in this sample.
Second, diagnostic group did not diﬀerentiate the levels
of stigma experienced by subjects, as measured by the Stigma
ExperiencesScale.Thisisinteresting,aswehypothesizedthat
individuals with Bipolar Disorder would have experienced
morestigma.Usuallybipolardisorderismoredisruptive,and
generally more noticeable to the lay public. However, peopleDepression Research and Treatment 7
Table 3: Reliability coeﬃcients for the 7-item Stigma Impact Scale.
Scale item
B i p o l a rD i s o r d e r( N = 57∗) Depression (N = 62∗)
Mean (SD) Item-rest correlation Mean (SD) Item-rest correlation
O nas c a l ew h e r e0i st h el o w e s tp o s s i b l e
amount, and 10 is the highest possible
amount, how much has stigma aﬀected you
personally?
Quality of life 5.6 (2.8) .67 4.7 (3.0) .72
Social contacts 5.9 (3.3) .70 5.3 (3.1) .74
Family relations 5.2 (3.5) .56 3.7 (3.2) .75
Self-esteem 6.2 (3.1) .47 6.0 (3.3) .67
O nas c a l ew h e r e0i st h el o w e s tp o s s i b l e
amount, and 10 is the highest possible
amount, how much has stigma aﬀected your
family as a whole?
Quality of Life 4.8 (3.8) .77 3.3 (3.3) .75
Social Contacts 4.6 (3.8) .82 3.2 (3.1) .76
Family relations 5.3 (3.2) .77 3.3 (3.2) .76
Chronbach’s Alpha reliability coeﬃcient .89 .91
Mean scale score (SD)
∗∗ 37.5(18.3) 29.5 (18.1)
CI 32.6–42.3 24.9–34.1
∗Note reduced sample size. Only respondents who answered all scale questions are included in the above table. ∗∗t (117 df) = 2.38, P = 0.019.
Table 4: Final model summary.
Model Coeﬃcients R2 change F statistic (for change) Signiﬁcance of F change
Average (constant) 5.95
+ Stigma Experiences Scale Score 3.96 .338 55.135(df=1,108) <.001
+ Diagnostic Group 8.96 .058 10.228(df=1,107) <.001
Stigma impact score = 5.95 + 3.93x (stigma experience score) + 8.96x (0 = depression; 1 = bipolar).
with depression may be more sensitive and thus report more
stigmatizing experiences. In any case this ﬁnding requires
further study, conﬁrmation with a larger probability sample
that will ideally take into account current diagnosis and
episode (e.g., depressed versus hypo/manic).
Our third ﬁnding was that the diagnostic group did
diﬀerentiate on the basis of stigma impacts (as measured by
the Stigma Impact Scale). Participants with bipolar disorder
reported signiﬁcantly greater psychosocial impact of stigma
both for themselves and for their family members. This
was an expected ﬁnding, as bipolar disorder is considered
more severe compared to depression, and more disruptive
behaviour is associated with bipolar disorder, which may
result in a higher impact of stigma. The reported experiences
within the two groups were also unexpectedly similar. We
believe that this should be examined more closely with
speciﬁc attention paid to how the impact may be changing
with time, and examining the relationship between the
current mental state and degree of stigma impact.
The fourth main ﬁnding showed that the frequency
of stigmatizing experiences was the strongest predictor of
stigma impact, more so than diagnostic group or any other
socio-demographic characteristic. One-third of the variance
in stigma impact could be explained by the stigmatizing
experiences. Additionally, a small but signiﬁcant amount
of variance (5.2%) was explained by diagnostic group. All
other sociodemographic or clinical characteristics did not
prove to be predictive in this sample. This is a particularly
important ﬁnding as far as our understanding of illness
stigma is concerned. This suggests that if we are able to
inﬂuence the frequency of stigmatizing experiences, through
antistigma programs, we may be able to reduce the impact as
well.
Past-population-based research has shown that members
of the general public hold diﬀerent stereotypes for diﬀerent
diagnostic groups. In a large multinational study Pescosolido
and colleagues [8] reported that people in the general public,
regardless of the social situation, are more likely to distance
themselves from people with schizophrenia than people
with depression. This research would suggest that stigma
experiences should diﬀer depending on diagnosis. However,
our results suggest that the public may not make diagnostic
distinctions when they interact with people with a mental
illness; at least with respect to distinctions between those8 Depression Research and Treatment
with depression and bipolar disorder. In our research, people
with major depression and bipolar disorder described a
similar range of stigma experiences.
Not only are the stigmatizing experiences of individuals
who have a mental illness important, but also the psychoso-
cial impact of these experiences is equally important to
quantify and understand. The stigma impact scale revealed
that individuals with bipolar disorder felt more psychosocial
impact from their experiences with stigma than did people
with depression. As well, they reported a more negative
impact on their family members. Anecdotally, in the com-
munity, people with bipolar disorder experience more self-
stigma, especially related to portrayals in the media, and
this may be related to the greater impact felt from their
stigmatizing experiences. Results from this study highlight
the importance of diﬀerentiating between the type and
frequency of stigma experiences that are reported by people
with a mental illness and their psychosocial impacts.
Stigma due to mental illness is a pervasive phenomenon.
This is seen in the high level of endorsement of items in the
stigmatizing experiences scale. Seven of the ten items of the
stigma experiences scale were endorsed by at least 50% by
both individuals with depression and bipolar disorder, with
peak endorsement reaching 73.3%.
The relationship between the frequency of stigmatizing
experiences and their impact has not been fully elucidated.
We found that one-third of the impact of stigma expe-
rienced by our sample subjects was explained by stigma
experiences, and another 5% was explained by diagnosis.
Given that the model explained just over a third of the
variation, there are many additional factors contributing
to the impact of stigma that still remain to be discovered.
An interesting future direction would be to examine the
extent to which culture modiﬁes the impact of stigmatizing
experiences on psychosocial domains. Investigation into
attributes, resilience factors, and social supports, which may
protect individuals from the negative impact of stigma,
also remains to be explored. The Inventory of Stigmatizing
Experiences represents one tool needed to fully characterize
the eﬀects of stigma felt by people suﬀering mood disorders
as well as other mental illnesses. Now that the internal
consistency of the scales has been demonstrated in both
heterogeneous and homogeneous clinic populations, future
research is needed to assess the validity of these scales: to
determine whether they are associated with other stigma-
related constructs (such as self-esteem or empowerment)
in predictable ways and to determine whether they predict
clinical outcomes such as recovery, medication adherence, or
relapse. It will also be important to determine if the scale
scores are sensitive to change so that they could be used to
evaluate anti stigma interventions.
One limitation of the study is that participants were
recruited from a tertiary referral university centre and
may represent a more severely ill and chronic population.
Individuals who attended the clinic more frequently would
have had a greater probability of being included in our
convenience sample. There may also be a bias toward older
individuals for the same reason. While this should not aﬀect
our ability to assess the internal consistency of the scales,
the impact of selection bias on our descriptive ﬁndings is
diﬃcult to evaluate. On the one hand, people with more
chronic conditions may perceive a higher degree of stigma,
but on the other, they may be able to deal better with the
impact due to the fact that they have been in treatment for
some time. In future studies, it will be important to ensure a
more representative sampling in order to evaluate the nature
of illness severity and duration on stigma experiences and
impact. Also, as our study reﬂects patients recruited between
2003 and 2007, we need to address the time changes with a
future study.
Inconclusion,itisimportanttoassessstigmaexperiences
and their impact from the perspective of people who are
aﬀected by mental illness. Research in this area has been
hampered by the lack of psychometrically tested scales. This
research has demonstrated that the Inventory of Stigma
Experiences, which was originally developed for use in a
heterogeneous sample of outpatients, also produces reliable
results in a diagnostically homogeneous sample. Participants
reported a high degree of stigmatizing experiences and the
extent of experiences was similar in depression and bipolar
disorder.
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